Avances en el diagnóstico de las vasculitis de vasos de gran calibre: identificación de biomarcadores y estudios de imagen

Villa, Ignacio; Agudo Bilbao, Mario; Martínez-Taboada, Víctor M.
Reumatol. clín. (Barc.) ; 7(supl.3): 22-27, dic. 2011.
Artículo en Español | IBECS (España) | ID: ibc-147313

Documentos relacionados

  1. Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
  2. Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017.
  3. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.
  4. New Therapeutic Approaches to Large-Vessel Vasculitis.
  5. [Pathogenesis of large vessel vasculitides].
  6. Response to: 'Correspondence to 'Slope sign': a feature of large vessel vasculitis?' by Milchert <i>et al</i>.
  7. Incidence of primary large vessel vasculitis in Norfolk, UK from 2011 to 2020.
  8. Cough as a clinical manifestation of large vessel vasculitis.
  9. Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitis.
  10. Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis.